chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Blood test, Burning sensation, Injection site pain, Localised infection, Pain in extremity
Clinical narrative: This spontaneous case, reported by other non-healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725019), concerns a 33-year-old, adult female patient. The patient's current illness at the time of vaccination included cold. The patient's current conditions included asthma and allergy to aspirin, MOTRIN, penicillin, vancomycin, tramadol. The patient's concomitant medications included prednisone, albuterol, AFRIN. On 03-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number: XF32508, expiry date: not reported) and PNEUMOVAX (dose: 1 DF, route of administration: injection, anatomical location: right arm, batch number: N019348, expiry date: not reported). The patient had pain at the time of flu vaccine administration, but had no complaints when pneumococcal vaccine was given. The patient had burning sensation in the arm, swelling overnight and fever. On 04-Nov-2017, she had developed large area infection on the right arm inside and outside the skin which spread down to arm and back. The arm was heavily swollen and painful throughout. On 05-Nov-2017, the patient went to the emergency room for the event. The patient was treated with doxycycline twice a day for 10 days. On an unspecified date, the patient had follow-up appointment with primary care physician and unspecified bloodworks. At the time of the report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 33.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Peripheral swelling, Pyrexia
Clinical narrative: This spontaneous case, reported by other non-healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725019), concerns a 33-year-old, adult female patient. The patient's current illness at the time of vaccination included cold. The patient's current conditions included asthma and allergy to aspirin, MOTRIN, penicillin, vancomycin, tramadol. The patient's concomitant medications included prednisone, albuterol, AFRIN. On 03-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: right arm, batch number: XF32508, expiry date: not reported) and PNEUMOVAX (dose: 1 DF, route of administration: injection, anatomical location: right arm, batch number: N019348, expiry date: not reported). The patient had pain at the time of flu vaccine administration, but had no complaints when pneumococcal vaccine was given. The patient had burning sensation in the arm, swelling overnight and fever. On 04-Nov-2017, she had developed large area infection on the right arm inside and outside the skin which spread down to arm and back. The arm was heavily swollen and painful throughout. On 05-Nov-2017, the patient went to the emergency room for the event. The patient was treated with doxycycline twice a day for 10 days. On an unspecified date, the patient had follow-up appointment with primary care physician and unspecified bloodworks. At the time of the report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Rash, Rash maculo-papular
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725118), concerns a 56-year-old, adult, female patient. The patient's current conditions included allergic to iodine and shrimp. On 11-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose:0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF34309 and expiry date: not reported). On 28-Oct-2017, after 17 days of vaccination, the patient had maculo-papular rash over abdomen and left side. The patient was taken to urgent care and treated with anti-histamines for one week and there was no improvement. It was reported that, 2 days ago the patient received ZYRTEC and no changes had seen in a rash. No lab tests were performed to the patient. The outcome of the event was not recovered. The reporter assessed the case as non-serious.
Age: 37.0
Sex: M
Vaccine: DTAP, FLU4, HEPA
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case, reported by non-health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725127), concerns a 37-year-old, adult, male patient. The patient's historical condition included soreness and pain (on an unspecified date). The current condition included allergy to meloxicam (from an unspecified date). The patient had no concomitant medications. On 13-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported). On the same day, the patient was administered with non-company suspect product HAVRIX (route of administration: intramuscular, anatomical location: right arm, dose, batch number and expiry date: not reported) and INFANRIX (route of administration: intramuscular, anatomical location: left arm, dose, batch number and expiry date: not reported). On 14-Oct-2017, after 1 day of vaccination, the patient had sore in arms and fever with temperature of 100.3 degrees. It was reported that, the effects were very mild and completely expected. At the time of report, the patient had recovered from the events (pain in arm and fever). The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Feeling hot, Rash generalised
Clinical narrative: This spontaneous case, reported by physician to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725198), concerns a 42-year-old adult female patient. The patient had no medical history and no known allergies. The patient did not receive any concomitant medications. On 01-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: XF34509. On 02-Nov-2017, the patient woke up in the morning felt hot and noted a slight rash. On 03-Nov-2017, in the morning she noted rash all over the body. It was reported that, the patient was not taking any medications. No recent illnesses, coughs, colds, fever, chills, nausea, vomiting and diarrhoea were observed. It was reported that, the patient had not taken over-the-counter or prescription medications. The patient denied any shortness of breath and pain at that time. The patient was to take BENADRYL (25-50mg, QID (four times daily)). It was reported that, the physician had a long discussion with the patient regarding the severe allergic reaction or anaphylaxis would be like and go for emergency department immediately if respiratory difficulty was experienced. It was reported, that the patient would be available whenever needed. The outcome of the events (rash, rash generalised and feeling hot) recovered. The reporter assessed the case as non-serious. Non-significant case correction was received with IRD 21-Feb-2018: Narrative was corrected (word decision was changed to discussion, amended accordingly the discussion between the physician and patient).
Sex: M
Vaccine: FLU4
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: This spontaneous case, reported by Non-health professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725205), concerns a 54-year-old adult male patient. The patient's current condition included human immunodeficiency virus syndrome (HIV). The patient's concomitant medications included TRUVADA, ISENTRESS, INTELENCE and LAMICTAL for an unknown indication. On 12-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported). On the same day late on the date after vaccination, the patient's left arm got hurt as expected (previous experience). On the next day the patient experienced pain which got subsided slightly but then began to worse. On 16-Oct-2017, the patient could not lift his arm (more than 50 percent) with moderate to severe pain. It was reported that, the patient decided to seek the doctor due to worsening of pain. At the time of this report, the outcome of the events was not recovered. The reporter assessed this case as non-serious.
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: Asthenia, Fatigue, Immediate post-injection reaction, Influenza like illness, Injected limb mobility decreased
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725216), concerns a 53-year-old, adult female patient. The patient had no medical history or allergy. The concomitant medications and current illness were unknown. On 21-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF30309, expiry date: not reported). On the same day, immediately after the vaccination, the patient had pain at the site of the injection (central area of deltoid muscle). It was reported that she was vaccinated neither too high nor too low on the deltoid. The patient also had pain in the shoulder which lead to restricted strength and flexion in the left shoulder since vaccination. Three days after vaccination (unspecified date in Oct-2017), the patient developed flu-like symptoms (myalgia, fatigue, but had no fever). On an unspecified date, the patient visited a physician due to prolonged pain (reported as 16 days). Upon visual examination of the injection site, the patient had no bruising or swelling. At the time of this report, the patient had not recovered from all the events. The reporter assessed the case as non-serious. Non-significant case correction received 21-Feb-2018: The case comment was corrected (from 'considering the temporal relationship and site of event occurrences the events are considered as related' to 'considering the temporal relationship, the events are considered as related').
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Myalgia
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725216), concerns a 53-year-old, adult female patient. The patient had no medical history or allergy. The concomitant medications and current illness were unknown. On 21-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF30309, expiry date: not reported). On the same day, immediately after the vaccination, the patient had pain at the site of the injection (central area of deltoid muscle). It was reported that she was vaccinated neither too high nor too low on the deltoid. The patient also had pain in the shoulder which lead to restricted strength and flexion in the left shoulder since vaccination. Three days after vaccination (unspecified date in Oct-2017), the patient developed flu-like symptoms (myalgia, fatigue, but had no fever). On an unspecified date, the patient visited a physician due to prolonged pain (reported as 16 days). Upon visual examination of the injection site, the patient had no bruising or swelling. At the time of this report, the patient had not recovered from all the events. The reporter assessed the case as non-serious. Non-significant case correction received 21-Feb-2018: The case comment was corrected (from 'considering the temporal relationship and site of event occurrences the events are considered as related' to 'considering the temporal relationship, the events are considered as related').
Age: 29.0
Sex: M
Vaccine: FLU4
Symptoms: Arthralgia, Chills, Dizziness, Headache, Nausea
Clinical narrative: This is spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725265), concerns a 29-year-old male patient. It was reported that, the patient received an unspecified vaccine and had similar reaction one year earlier. On 01-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (1 as reported), route of administration: injection (SYR as reported), anatomical location: left arm, batch number: not reported). On the same day, at 10:00pm 12:00 hours the patient had intense chills, intense joint aches (including knee, spine, fingers) and nausea. At 10:00pm 16:00hours, the patient had intense headache, at 10:00pm 24:00hours, the patient had dizziness. The outcome of the events (chills, headache, nausea, dizziness and arthralgia) recovered. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLU4, PPV
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725308), concerns a 61-year-old, adult, female patient. The patient had no medical history or allergy. The patient did not receive any concomitant medication. On 05-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: XF32908 and expiry date: not reported) and non-company suspect product PNEUMOVAX (route of administration: intramuscular, anatomical location: right arm, batch number: N013521, dose and expiry date: not reported). On 06-Nov-2017, after 2 days of vaccination, the patient's arm was red, swollen and hot. The patient received Ibuprofen, which did not help. On 07-Nov-2017, reported as on Monday, the patient was referred to doctor. At the time of this report, the outcome of the events was not reported. The reporter assessed the events as non-serous. Non-significant case correction received with the IRD 21-Feb-2018: The narrative was corrected to align date with weekday. Non-significant case correction received with the IRD 21-Feb-2018: Sentence reformation was done in the narrative in last correction line.
Sex: U
Vaccine: FLU4
Symptoms: Asthenia, Injected limb mobility decreased, Injection site pain, Insomnia, Laboratory test
Clinical narrative: This spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725310), concerns a patient of unspecified age and gender. The patient's medical history was not reported. On an unspecified date, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as N/A), route of administration: intramuscular, anatomical location: left arm, batch number: 00944611A and expiry date: not reported). On an unspecified date, the patient experienced severe pain in the left shoulder consisting of dull pain, throbbing, stabbing pain, sharp pain, burning. The patient also had weakness and difficulty in moving. Reportedly, the patient had been experiencing these symptoms for 2 weeks which affected sleep and ability to use arm. It was reported that the patient underwent unspecified lab tests (results not reported). At the time of this report, the patient had not recovered from the events. The reporter assessed this report as non-serious.  At the time of this report, the patient had not recovered from the events. The reporter assessed this report as non-serious.
Sex: U
Vaccine: FLU4
Symptoms: Pain
Clinical narrative: This spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725310), concerns a patient of unspecified age and gender. The patient's medical history was not reported. On an unspecified date, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as N/A), route of administration: intramuscular, anatomical location: left arm, batch number: 00944611A and expiry date: not reported). On an unspecified date, the patient experienced severe pain in the left shoulder consisting of dull pain, throbbing, stabbing pain, sharp pain, burning. The patient also had weakness and difficulty in moving. Reportedly, the patient had been experiencing these symptoms for 2 weeks which affected sleep and ability to use arm. It was reported that the patient underwent unspecified lab tests (results not reported). At the time of this report, the patient had not recovered from the events. The reporter assessed this report as non-serious.  At the time of this report, the patient had not recovered from the events. The reporter assessed this report as non-serious.
Age: 89.0
Sex: M
Vaccine: FLU4
Symptoms: Blood glucose, Fatigue, Feeding disorder, Malaise
Clinical narrative: This spontaneous case, reported by Non-health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725397), concerns a 89-year-old, elderly, male patient. It was reported that, as the patient was immunocompromised and done with stem cell transplant procedure and a few years ago, the patient had pneumonia. The patient's concomitant medications included dextran 70 w/hypromellose, ferrous gluconate, INSULIN NOVOLIN and NOVOLIN R (on an unspecified date). On 24-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: XF33008 and expiry date: not reported). On 25-Oct-2017, after 1 day of vaccination, the patient felt wiped out (as reported). It was reported that, the patient was unable to get out of bed on next morning and was unable to eat until next day. Later, he felt unwell. No lab tests were done. At the time of the report, the patient had recovered from the events (unable to eat, feeling unwell and tired out). The reporter assessed this case as non-serious. Significant case correction received 21-Feb-2018: The immunocompromised was captured as current condition in patient's medical history. The 'as determined' causality of the event (feeding disorder) from related to unassessable and case comment was corrected.
Age: 54.0
Sex: F
Vaccine: FLU4
Symptoms: Balance disorder, Chills, Dizziness, Pyrexia
Clinical narrative: This is spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725533), concerns a 54-year-old, adult female patient. The patient had no medical history reported. The patient's concomitant medication included colecalciferol and SYNTHROID. On 07-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5ml, route of administration: JET (as reported), anatomical location: left arm, batch number and expiry date not reported). On 08-Nov-2017, 2 days after vaccination, the patient had fever and felt dizzy. It was reported that, the patient was unsteady and had chills. At the time of this report, the patient had not yet recovered from the events (fever, dizzy, unsteady and chills). The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Injection site bruising, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725670), concerns a 53-year-old, adult female patient. The patient's historical drug included gentamycin for an unknown indication (dates not reported). Current condition included hypertension since an unspecified date. Concomitant medications included Lisinopril, estradiol and MVI for an unknown indication. On 07-Nov-2017, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as UNK), route of administration: intramuscular, anatomical location: right arm, batch number: XF32608 and expiry date: not reported). On the same day after vaccination, the patient experienced local reaction at injection site, reportedly, warmth, redness, swelling and bruising. She also had "flushing" redness on skin at bilateral upper arms and upper chest. The skin was warm to touch with mild itching. It was reported that the mild reaction had not worsened but it had not resolved either. At the time of this report, the patient had not recovered from the events. The reporter assessed this report as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Local reaction, Pruritus, Skin warm
Clinical narrative: This spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725670), concerns a 53-year-old, adult female patient. The patient's historical drug included gentamycin for an unknown indication (dates not reported). Current condition included hypertension since an unspecified date. Concomitant medications included Lisinopril, estradiol and MVI for an unknown indication. On 07-Nov-2017, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as UNK), route of administration: intramuscular, anatomical location: right arm, batch number: XF32608 and expiry date: not reported). On the same day after vaccination, the patient experienced local reaction at injection site, reportedly, warmth, redness, swelling and bruising. She also had "flushing" redness on skin at bilateral upper arms and upper chest. The skin was warm to touch with mild itching. It was reported that the mild reaction had not worsened but it had not resolved either. At the time of this report, the patient had not recovered from the events. The reporter assessed this report as non-serious.
Age: 1.0
Sex: F
Vaccine: FLU4, MMR, PNC13, VARCEL
Symptoms: Ear discomfort, Ear infection, Ear, nose and throat examination, Feeling abnormal, Injection site rash
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725694), concerning a 01-year-old, female infant. The patient's current illness included common cold and teething. The patient's concurrent medications were not reported. On 27-Oct-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1 dose, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). On the same day, the patient received MMR II (dose: 1 DF, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). On the same day, the patient received PREVNAR 13 (dose: 4 DF, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). On the same day, the patient received VARIVAX (dose: 1 DF, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). The patient had terrible time since the day she was vaccinated. On 28-Oct-2017, 1 day after vaccination, the patient was sick with fever. On 30-Oct-2017 (Monday), she was taken to hospital and was diagnosed with double ear infection and upper respiratory infection. Later, she was prescribed with AUGMENTIN antibiotic for 10 days. As the patient wasn't better, she was taken to the doctor on 01-Nov-2017 (Wednesday). On 06-Nov-2017 (Sunday), she had fever of 101 and was tugging at her ear. So, the patient was taken to urgent care where she was diagnosed with severe right ear infection and was prescribed with Z-PAK 10-day therapy in addition to AUGMENTIN. On an unspecified date in Nov-2017 (Monday), she was still miserable and on Tuesday (unspecified date in Nov-2017), as she seemed in good spirits, she was sent to day care. At 10 am, the patient was miserable and zoned out. Hence, she was taken to the doctor and they said that everything seemed fine. On 08-Nov-2017, around 8:30 am, a big welt was observed at the injection site for two vaccines. Within a couple of hours, the patient had dots all over the arms, legs and torso. She was taken to the doctor and was diagnosed as viral infection. It was reported that the patient underwent ear exam, eye exam, throat exam and belly exam but the results were not reported. At the time of this report, the patient had not recovered from all the events. The reporter assessed this case as non-serious. Non-significant case correction received 21-Feb-2018: Narrative was corrected (Monday was replaced with 30-Oct-2017 and 'around 8:30 am' was changed to 'on 08-Nov-2017, around 8:30 am'). Amended accordingly.
Age: 1.0
Sex: F
Vaccine: FLU4, MMR, PNC13, VARCEL
Symptoms: Injection site reaction, Malaise, Ophthalmological examination, Pyrexia, Rash
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725694), concerning a 01-year-old, female infant. The patient's current illness included common cold and teething. The patient's concurrent medications were not reported. On 27-Oct-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1 dose, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). On the same day, the patient received MMR II (dose: 1 DF, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). On the same day, the patient received PREVNAR 13 (dose: 4 DF, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). On the same day, the patient received VARIVAX (dose: 1 DF, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). The patient had terrible time since the day she was vaccinated. On 28-Oct-2017, 1 day after vaccination, the patient was sick with fever. On 30-Oct-2017 (Monday), she was taken to hospital and was diagnosed with double ear infection and upper respiratory infection. Later, she was prescribed with AUGMENTIN antibiotic for 10 days. As the patient wasn't better, she was taken to the doctor on 01-Nov-2017 (Wednesday). On 06-Nov-2017 (Sunday), she had fever of 101 and was tugging at her ear. So, the patient was taken to urgent care where she was diagnosed with severe right ear infection and was prescribed with Z-PAK 10-day therapy in addition to AUGMENTIN. On an unspecified date in Nov-2017 (Monday), she was still miserable and on Tuesday (unspecified date in Nov-2017), as she seemed in good spirits, she was sent to day care. At 10 am, the patient was miserable and zoned out. Hence, she was taken to the doctor and they said that everything seemed fine. On 08-Nov-2017, around 8:30 am, a big welt was observed at the injection site for two vaccines. Within a couple of hours, the patient had dots all over the arms, legs and torso. She was taken to the doctor and was diagnosed as viral infection. It was reported that the patient underwent ear exam, eye exam, throat exam and belly exam but the results were not reported. At the time of this report, the patient had not recovered from all the events. The reporter assessed this case as non-serious. Non-significant case correction received 21-Feb-2018: Narrative was corrected (Monday was replaced with 30-Oct-2017 and 'around 8:30 am' was changed to 'on 08-Nov-2017, around 8:30 am'). Amended accordingly.
Age: 1.0
Sex: F
Vaccine: FLU4, MMR, PNC13, VARCEL
Symptoms: Upper respiratory tract infection, Urticaria, Viral infection
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725694), concerning a 01-year-old, female infant. The patient's current illness included common cold and teething. The patient's concurrent medications were not reported. On 27-Oct-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1 dose, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). On the same day, the patient received MMR II (dose: 1 DF, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). On the same day, the patient received PREVNAR 13 (dose: 4 DF, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). On the same day, the patient received VARIVAX (dose: 1 DF, route of administration: injection, anatomical location: leg, batch number and expiry date: not reported). The patient had terrible time since the day she was vaccinated. On 28-Oct-2017, 1 day after vaccination, the patient was sick with fever. On 30-Oct-2017 (Monday), she was taken to hospital and was diagnosed with double ear infection and upper respiratory infection. Later, she was prescribed with AUGMENTIN antibiotic for 10 days. As the patient wasn't better, she was taken to the doctor on 01-Nov-2017 (Wednesday). On 06-Nov-2017 (Sunday), she had fever of 101 and was tugging at her ear. So, the patient was taken to urgent care where she was diagnosed with severe right ear infection and was prescribed with Z-PAK 10-day therapy in addition to AUGMENTIN. On an unspecified date in Nov-2017 (Monday), she was still miserable and on Tuesday (unspecified date in Nov-2017), as she seemed in good spirits, she was sent to day care. At 10 am, the patient was miserable and zoned out. Hence, she was taken to the doctor and they said that everything seemed fine. On 08-Nov-2017, around 8:30 am, a big welt was observed at the injection site for two vaccines. Within a couple of hours, the patient had dots all over the arms, legs and torso. She was taken to the doctor and was diagnosed as viral infection. It was reported that the patient underwent ear exam, eye exam, throat exam and belly exam but the results were not reported. At the time of this report, the patient had not recovered from all the events. The reporter assessed this case as non-serious. Non-significant case correction received 21-Feb-2018: Narrative was corrected (Monday was replaced with 30-Oct-2017 and 'around 8:30 am' was changed to 'on 08-Nov-2017, around 8:30 am'). Amended accordingly.
Age: 34.0
Sex: F
Vaccine: FLU4
Symptoms: Chest discomfort
Clinical narrative: This spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725752), concerns a 34-year-old, adult female patient. The patient's current condition included cold since an unspecified date. Concomitant medications included CENTRUM and Probiotic. On 07-Nov-2017, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: 00944611A and expiry date: not reported). On 07-Nov-2017, at night (few hours after the vaccination), the patient experienced chest tightness. Reportedly, it was worse when she bend over to pick something. Outcome of the event was reported as unknown. The reporter assessed this report as non-serious.
Age: 26.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Axillary pain, Chest discomfort, Chest pain, Fatigue, Flank pain
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725842), concerns a 26-year-old, adult, female patient. The patient's current condition included Systemic lupus erythematosus (SLE), Sjogren's syndrome, rheumatoid arthritis (RA), fibromyalgia, Reynaud's, interstitial cystitis, mild pulmonary hypertension, chronic migraine, livedo reticularis, gastro-oesophageal reflux disease (GERD) disease, irritable bowel syndrome (IBS), gastroparesis, heart murmur, esophagitis, vasovagal syncope and allergic to verapamil, codeine, sulpha drugs, CYMBALTA and erythromycin. The patient's concomitant medications included hydroxychloroquine, gabapentin, tramadol, pantoprazole, midodrine, LINZESS, magnesium, turmeric, TYLENOL. On 01-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5ml, route of administration: injection, anatomical location: right arm, batch number and expiry date: not reported) and PNEUMOVAX (route of administration: injection, anatomical location: left arm, manufacturer, trade, batch number and expiry date: not reported). On the same day after vaccination, the patient developed swelling in arm, red rash, extreme pain down the left armpit chest and side. The patient also had muscle spasms, muscle stiffness in arms and legs, and neck stiffness. The patient also experienced blurry vision, headache, chest pain and pressure, fatigue, nausea and vomiting. The patient had swollen lymph nodes. On 03-Nov-2017, the patient went to emergency room (ER) where she was treated with BENADRYL and TORADOL injection. It was reported that staff was unable to administered intravenous (IV) for contrast magnetic resonance imaging (MRI) and unable to find the suitable veins. On an unspecified day, the patient's blood pressure and heart rate was also monitored for several hours. On an unspecified date, the patient recovered from the events. The reporter assessed the case as non-serious. Significant case correction received 21-Feb-2018: Description to be coded for the event vomiting and case comment was corrected. As determined causality for the events swelling in arm, red rash and extreme pain down the left armpit were corrected to not related from unassessable.
Age: 26.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Headache, Lymphadenopathy, Muscle spasms, Musculoskeletal stiffness, Nausea
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725842), concerns a 26-year-old, adult, female patient. The patient's current condition included Systemic lupus erythematosus (SLE), Sjogren's syndrome, rheumatoid arthritis (RA), fibromyalgia, Reynaud's, interstitial cystitis, mild pulmonary hypertension, chronic migraine, livedo reticularis, gastro-oesophageal reflux disease (GERD) disease, irritable bowel syndrome (IBS), gastroparesis, heart murmur, esophagitis, vasovagal syncope and allergic to verapamil, codeine, sulpha drugs, CYMBALTA and erythromycin. The patient's concomitant medications included hydroxychloroquine, gabapentin, tramadol, pantoprazole, midodrine, LINZESS, magnesium, turmeric, TYLENOL. On 01-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5ml, route of administration: injection, anatomical location: right arm, batch number and expiry date: not reported) and PNEUMOVAX (route of administration: injection, anatomical location: left arm, manufacturer, trade, batch number and expiry date: not reported). On the same day after vaccination, the patient developed swelling in arm, red rash, extreme pain down the left armpit chest and side. The patient also had muscle spasms, muscle stiffness in arms and legs, and neck stiffness. The patient also experienced blurry vision, headache, chest pain and pressure, fatigue, nausea and vomiting. The patient had swollen lymph nodes. On 03-Nov-2017, the patient went to emergency room (ER) where she was treated with BENADRYL and TORADOL injection. It was reported that staff was unable to administered intravenous (IV) for contrast magnetic resonance imaging (MRI) and unable to find the suitable veins. On an unspecified day, the patient's blood pressure and heart rate was also monitored for several hours. On an unspecified date, the patient recovered from the events. The reporter assessed the case as non-serious. Significant case correction received 21-Feb-2018: Description to be coded for the event vomiting and case comment was corrected. As determined causality for the events swelling in arm, red rash and extreme pain down the left armpit were corrected to not related from unassessable.
Age: 26.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Peripheral swelling, Rash erythematous, Vision blurred, Vomiting
Clinical narrative: This spontaneous case, reported by other health care professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725842), concerns a 26-year-old, adult, female patient. The patient's current condition included Systemic lupus erythematosus (SLE), Sjogren's syndrome, rheumatoid arthritis (RA), fibromyalgia, Reynaud's, interstitial cystitis, mild pulmonary hypertension, chronic migraine, livedo reticularis, gastro-oesophageal reflux disease (GERD) disease, irritable bowel syndrome (IBS), gastroparesis, heart murmur, esophagitis, vasovagal syncope and allergic to verapamil, codeine, sulpha drugs, CYMBALTA and erythromycin. The patient's concomitant medications included hydroxychloroquine, gabapentin, tramadol, pantoprazole, midodrine, LINZESS, magnesium, turmeric, TYLENOL. On 01-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5ml, route of administration: injection, anatomical location: right arm, batch number and expiry date: not reported) and PNEUMOVAX (route of administration: injection, anatomical location: left arm, manufacturer, trade, batch number and expiry date: not reported). On the same day after vaccination, the patient developed swelling in arm, red rash, extreme pain down the left armpit chest and side. The patient also had muscle spasms, muscle stiffness in arms and legs, and neck stiffness. The patient also experienced blurry vision, headache, chest pain and pressure, fatigue, nausea and vomiting. The patient had swollen lymph nodes. On 03-Nov-2017, the patient went to emergency room (ER) where she was treated with BENADRYL and TORADOL injection. It was reported that staff was unable to administered intravenous (IV) for contrast magnetic resonance imaging (MRI) and unable to find the suitable veins. On an unspecified day, the patient's blood pressure and heart rate was also monitored for several hours. On an unspecified date, the patient recovered from the events. The reporter assessed the case as non-serious. Significant case correction received 21-Feb-2018: Description to be coded for the event vomiting and case comment was corrected. As determined causality for the events swelling in arm, red rash and extreme pain down the left armpit were corrected to not related from unassessable.
Age: 6.0
Sex: F
Vaccine: FLU4
Symptoms: Blood creatine phosphokinase increased, C-reactive protein normal, Full blood count abnormal, Gait inability, Injection site pain
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725978), concerns a 6-year-old female child patient. It was reported that, the patient had minor upper respiratory tract infection (URI as reported) few weeks prior to vaccination. The patient was allergic to tree nut. On 26-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5ml (UNK as reported), anatomical location: left leg, batch number: not reported, route of administration: not reported). On 03-Nov-2017, the patient had myositis at the site of injection noted with swelling, pain and inability to walk with that leg. It was reported that, myositis worsened 10 days after the vaccination. The patient's lab data included full blood count abnormal, CPK (creatinine phosphate kinase) elevated, C-reactive protein and erythrocyte sedimentation rate was normal. X-ray showed mild swelling but otherwise remarkable (as reported). On physical examination, the patient's left thigh (where vaccine was given) swollen compared to right side, also tender and painful. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 6.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site reaction, Injection site swelling, Myositis, Red blood cell sedimentation rate normal, X-ray normal
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 725978), concerns a 6-year-old female child patient. It was reported that, the patient had minor upper respiratory tract infection (URI as reported) few weeks prior to vaccination. The patient was allergic to tree nut. On 26-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5ml (UNK as reported), anatomical location: left leg, batch number: not reported, route of administration: not reported). On 03-Nov-2017, the patient had myositis at the site of injection noted with swelling, pain and inability to walk with that leg. It was reported that, myositis worsened 10 days after the vaccination. The patient's lab data included full blood count abnormal, CPK (creatinine phosphate kinase) elevated, C-reactive protein and erythrocyte sedimentation rate was normal. X-ray showed mild swelling but otherwise remarkable (as reported). On physical examination, the patient's left thigh (where vaccine was given) swollen compared to right side, also tender and painful. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Injection site reaction, Vascular injury
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 726040), concerns a 63-year-old, adult female patient. The patient had no known history, allergy or current illness. There were no lab data for the patient. The patient's concomitant medications included, ADVAIR, gabapentin, VENTOLIN, temazepam, clorazepate, omeprazole, ranitidine, cyclobenzaprine, folic acid, vitamin D, Topamax, FIORICET, SYNTHROID, trazadone, WELLBUTRIN, simvastatin, fluocinonide cream for unknown indications. On 19-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: upper right arm, batch number: XF33108, expiry date: not reported). On the same day, patient had pain in the injected site (upper right arm). The patient consulted a physician, who told that her vein was hit (considered as vein injury). The outcome of the events venous injury and injection site pain was not reported. The reporter assessed the case as non-serious.
Age: 32.0
Sex: F
Vaccine: FLU4
Symptoms: Dysphagia, Eye swelling, Flushing, Headache
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 726168), concerns a 32-year-old, adult female patient. The patient's history, allergies, current illness and concomitant medications were unknown. On 05-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF33008, expiry date: not reported). Approximately after 2 hours of vaccination, the patient had difficulty in swallowing, headache, flushing and denied breathing trouble. The patient was  taken to the emergency department (ED), where unspecified treatment was given. Next day morning, the patient woke up with swollen eyes. At the time of this report, the patient had recovered from the events. The reporter assessed the case as non-serious.
Age: 44.0
Sex: F
Vaccine: FLU4
Symptoms: Chest pain, Dysgeusia, Dysphagia, Headache, Musculoskeletal stiffness
Clinical narrative: This is a spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 726171), concerns a 44-year-old, adult, female patient. The patent's medical history and concomitant medications were not reported. On 06-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, batch number: XF33308 (reported as XF3308), anatomical location and expiry date: not reported). On the same day, after the vaccination, the patient experienced left-sided chest ache, copper taste in mouth, neck, back, shoulder stiffness, fuzzy vision, dull headache and increased mucus which made swallowing difficult. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious. Non-significant case correction received with 21-Feb-2018: Narrative was corrected (difficult swallowing to swallowing difficult).
Age: 44.0
Sex: F
Vaccine: FLU4
Symptoms: Rhinorrhoea, Vision blurred
Clinical narrative: This is a spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 726171), concerns a 44-year-old, adult, female patient. The patent's medical history and concomitant medications were not reported. On 06-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, batch number: XF33308 (reported as XF3308), anatomical location and expiry date: not reported). On the same day, after the vaccination, the patient experienced left-sided chest ache, copper taste in mouth, neck, back, shoulder stiffness, fuzzy vision, dull headache and increased mucus which made swallowing difficult. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious. Non-significant case correction received with 21-Feb-2018: Narrative was corrected (difficult swallowing to swallowing difficult).
Sex: F
Vaccine: FLU4
Symptoms: Chest discomfort, Chest pain, Eye irritation, Eye swelling, Lung disorder
Clinical narrative: This spontaneous case, reported by other non-healthcare professional to VAERS and initially retrieved or 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 726212, concerns a 58-year-old-adult, female patient. The patient's historical conditions included cough and cold (ended in 1-Oct-2017) and the patient was allergic to penicillin. On 11-Sep-207, the patient was administered with AFLURIA (dose:0.5ml, route of administration: intramuscular, anatomical location: right arm, batch number: XF33408, expiry date: not reported). On the same day, approximately 3 hrs of vaccination, the patient had burning sensation in her eyes (felt like they had sandpaper) and felt like swollen. Approximately after 4 hrs of vaccination, the patient did not had breathing distress, but she felt like she had upper respiratory cold, felt that her chest was tight and burning sensation. On the next day, approximately after 19 hrs of vaccination, the patient's eyes were bright red and was swollen. The patient's face was swollen and felt like her lungs were compromised. It was reported that symptoms described about oculo-respiratory syndrome. Approximately after 29 hrs of vaccination, the patient's eyes were red, but not swollen, her chest feel normal and oedema on her face was decreasing. The outcome of the events was not recovered. The reporter considered this case as non-serious.